Personalis — cancer genomics (MRD testing)
| Filed | Insider | Role | Shares | Value | |
|---|---|---|---|---|---|
| 2026-02-13 | Tempus AI, Inc. | 10%-owner | 320,267 | $2,739,181 | Form 4 |
| Report | Date | Stance |
|---|---|---|
| #80 — Market Memo: January Musings | 2025-01-09 | LONG |
from2028 — cross-site stock view. Rebuilt at publish time.